Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v9-FR
Language French French
Date Updated 2022-04-18 2022-02-23
Drug Identification Number 02239630 02239630
Brand name TOBI TOBI
Common or Proper name TOBRAMYCIN SOLUTION TOBRAMYCIN SOLUTION
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 300MG 300MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 56 AMPULES 56 AMPULES
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-02-23 2022-02-23
Actual start date 2022-03-08
Estimated end date 2022-04-26 2022-04-12
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments